Neuphoria Therapeutics Inc. - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image: Luxshare Precision Industry’s planned $3.1 billion Hong Kong share sale highlights the Apple supplier’s expansion into electronics manufacturing, AI infrastructure and automotive technology.

Why is Apple supplier Luxshare Precision raising $3.1bn after its Shenzhen stock doubled?

Nuvectis Pharma just raised $100 million, so why are NVCT shareholders selling?

BMO’s planned acquisition of Euroz Hartleys Group’s Australian capital markets business highlights the growing strategic value of mining finance, institutional broking and cross-border dealmaking in Western Australia. Representative image.

Is BMO’s Euroz Hartleys acquisition the start of a new battle for Australian mining mandates?

Amdocs begins AI-led job cuts as Shimie Hortig reshapes telecom software group

Read More

Pharma Industry News

Scancell confirms Neuphoria reverse-merger talks as SCLP targets Nasdaq and Phase 3 funding

Scancell is discussing an all-share acquisition of Neuphoria Therapeutics that could secure a Nasdaq listing and strengthen funding options for the global Phase 3 trial of iSCIB1+.

June 29, 2026

web analytics